Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
FDA Inspection
•Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation•May 16, 2023

Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation – FDA Inspection, May 16, 2023

Record Details

This FDA Inspection record concerns Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation, with an inspection on May 16, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
Inspection Date
May 16, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Celeta S. Coves (Issuing Officer)
  • Tania Y. Hall
View Company Profile

ID · 733b6ce3-234f-4771-b68b-477ab58becf0

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1205562
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 1271.75(d)Donors with risks not determined ineligible
  2. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  3. 21 CFR 1271.50(a)Determination based on screening and testing
  4. 21 CFR 1271.90(c)Eligibility not required--warning labels
  5. 21 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
  6. 21 CFR 1271.55(c)Name and personal info on accompanying records
  7. 21 CFR 1271.50(a)Determination based on screening and testing
  8. 21 CFR 1271.55(c)Name and personal info on accompanying records
  9. 21 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
  10. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation

5
DateClassificationOfficeProject area
September 6, 2024NAILos Angeles District OfficeBlood and Blood Products
July 3, 2018NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
July 24, 2015NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 18, 2011NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
July 1, 2009OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
  • FDA Inspection 1248530 - 2024-09-06
  • FDA Inspection 1061280 - 2018-07-03
  • FDA Inspection 936926 - 2015-07-24
  • FDA Inspection 715545 - 2011-03-18
  • FDA Inspection 594231 - 2009-07-01

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.